Lawton J M, Conway L T, Crosson J T, Smith C L, Abraham P A
Arch Intern Med. 1985 May;145(5):950-1.
A single 45-g dose of intravenous ascorbic acid, a metabolic precursor of oxalate, was administered to a patient as adjuvant therapy for primary amyloidosis and the nephrotic syndrome. Acute oliguric renal failure occurred. Postmortem histopathologic examination of renal tissue revealed extensive intratubular deposition of crystalline material, which was confirmed as calcium oxalate by a microincineration technique. There were no extrarenal deposits of calcium oxalate. Plasma oxalate and ascorbic acid concentrations were increased. We conclude that therapy with high-dose ascorbic acid is a potential cause of oxalate nephropathy.
给一名原发性淀粉样变性和肾病综合征患者静脉注射一剂45克的草酸代谢前体——抗坏血酸作为辅助治疗。患者出现急性少尿性肾衰竭。肾脏组织的尸检组织病理学检查显示肾小管内有大量结晶物质沉积,通过微焚化技术证实为草酸钙。没有肾外草酸钙沉积。血浆草酸和抗坏血酸浓度升高。我们得出结论,高剂量抗坏血酸治疗是草酸肾病的一个潜在病因。